Stay updated on Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    15 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.3.1 was removed in the page history, indicating a minor site version update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:31:03.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    Revision: v3.3.1 was added and Revision: v3.2.0 was removed.
    Difference
    0.1%
    Check dated 2025-11-24T14:30:42.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The site-wide notice about potential delays due to funding has been removed and replaced with a prompt to check opm.gov for operating status updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2025-11-17T06:35:26.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The study record shows only the initial version with no substantive changes (no additions or deletions). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T01:14:19.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    - Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.
    Difference
    13%
    Check dated 2025-10-05T09:25:11.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or update a. No changes to core content, pricing, or stock are evident.
    Difference
    0.3%
    Check dated 2025-09-28T03:06:27.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial page.